RICTOR (Raptor Companion) encodes a critical component of the mechanistic target of rapamycin complex 2 (mTORC2), a key signaling hub that regulates cell survival, metabolism, cytoskeletal organization, and synaptic plasticity. RICTOR serves as the defining subunit that distinguishes mTORC2 from mTORC1, and its expression and activity are essential for normal neuronal function and are dysregulated in multiple neurodegenerative diseases. [1]
The RICTOR-mTOR complex (mTORC2) phosphorylates and activates several key AGC family kinases, including AKT (at Ser473), serum/glucocorticoid-regulated kinase 1 (SGK1), and protein kinase C (PKC) isoforms. These downstream targets regulate diverse cellular processes including glucose metabolism, lipid synthesis, protein synthesis, cell survival, and cytoskeletal dynamics. Within the central nervous system, mTORC2 signaling is particularly important for neuronal development, synaptic plasticity, mitochondrial function, and the response to neurotoxic insults. [2]
Dysregulation of RICTOR/mTORC2 signaling has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and other neurodegenerative disorders. The protein represents both a biomarker of neuronal dysfunction and a potential therapeutic target for interventions aimed at preserving neuronal health and function.
| Attribute | Value | Source |
|---|---|---|
| Gene Symbol | RICTOR | [1:1] |
| Full Name | Raptor Companion | Original nomenclature |
| Chromosomal Location | 5p13.1 | NCBI Gene Database |
| Aliases | GIGYF1, AVO3, KIAA1999 | Various |
| NCBI Gene ID | 253782 | NCBI |
| UniProt ID | Q6R327 | UniProt |
| Ensembl ID | ENSG00000164327 | Ensembl |
| OMIM | 610027 | OMIM |
| Protein Length | 1,718 amino acids | UniProt |
| Molecular Weight | ~200 kDa | [1:2] |
RICTOR is a large protein of approximately 200 kDa with multiple functional domains:
The protein adopts a HEAT repeat fold, similar to other proteins in the mTOR signaling network. These repeats form a flexible solenoid structure that facilitates protein-protein interactions. RICTOR contains multiple WD40 repeat motifs at its C-terminus that are involved in substrate recruitment and localization.
RICTOR forms a stable complex with mTOR (the catalytic kinase subunit) and other components:
The stoichiometry of mTORC2 is approximately 1:1:1 for mTOR:RICTOR:mSIN1, with PROTOR1/2 present in sub-stoichiometric amounts.
RICTOR interacts with mTOR through its N-terminal domain, while mSIN1 binds to both mTOR and RICTOR. This tripartite interaction stabilizes the complex and is required for kinase activity. PROTOR1/2 bind to the RICTOR-mTOR interface but are not essential for catalytic activity.
mTORC2/RICTOR phosphorylates several key substrates:
The most well-characterized substrate of mTORC2 is AKT (also known as Protein Kinase B). RICTOR/mTORC2 phosphorylates AKT at Ser473, a site that primes AKT for full activation by PDK1 (which phosphorylates Thr308). This phosphorylation event is critical for AKT signaling in most cellular contexts. [3]
AKT downstream effects include:
SGK1 is another important substrate of mTORC2:
mTORC2 phosphorylates and activates conventional PKC isoforms:
RICTOR/mTORC2 regulates multiple cellular processes:
The AKT-S473 phosphorylation by mTORC2 is a critical survival signal:
mTORC2 regulates cellular metabolism through:
mTORC2 influences cytoskeletal dynamics through:
Although mTORC1 is the primary regulator of translation, mTORC2 contributes indirectly through:
RICTOR is expressed in most human tissues with particularly high expression in:
Within the central nervous system, RICTOR shows:
RICTOR localizes to:
RICTOR/mTORC2 signaling is significantly dysregulated in Alzheimer's disease:
[4] demonstrated that mTORC2/AKT signaling deficits contribute to synaptic dysfunction and memory impairment in AD models.
RICTOR/mTORC2 regulates synaptic plasticity through:
In AD, dysregulated mTORC2 contributes to:
mTORC2 interacts with tau pathology:
Aβ affects mTORC2 signaling:
RICTOR is particularly important for dopaminergic neuron survival:
[5] demonstrated that RICTOR/mTORC2 signaling is essential for:
RICTOR interacts with alpha-synuclein (SNCA) pathogenesis:
RICTOR regulates mitochondrial dynamics:
RICTOR mutations and dysregulation are found in ALS:
[6] identified RICTOR mutations in ALS and frontotemporal dementia (FTD) cases:
mTORC2 signaling in motor neurons:
RICTOR/mTORC2 in HD:
[7] demonstrated that:
RICTOR/mTORC2 regulates multiple forms of synaptic plasticity:
mTORC2 contributes to LTP through:
mTORC2 also regulates LTD:
mTORC2 controls dendritic spine structure:
RICTOR/mTORC2 regulates axonal transport through:
mTORC2 influences local translation:
RICTOR regulates neuronal metabolism:
Targeting RICTOR/mTORC2 for neurodegenerative diseases:
For therapeutic development:
RICTOR knockout in mice:
Neuron-specific RICTOR deletion:
RICTOR overexpression:
Sarbassov DD, et al. Rictor, a binding partner of mTOR, defines a critical component of the rictor-mTOR complex. Curr Biol. 2005. 2005. ↩︎ ↩︎ ↩︎
Bodine SC, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy. Nat Med. 2001. 2001. ↩︎
Huang J, et al. The PTEN tumor suppressor gene and mTORC2 signaling in cancer. J Mol Med. 2009. 2009. ↩︎
Thoman C, et al. mTORC2/AKT signaling in Alzheimer's disease. Mol Neurodegener. 2019. 2019. ↩︎
Chiang C, et al. Rictor in dopaminergic neurons and Parkinson's disease. J Neurosci. 2018. 2018. ↩︎
Zhao Y, et al. RICTOR mutations in ALS and FTD. Nat Neurosci. 2019. 2019. ↩︎
Castellani CA, et al. mTORC2 in aging and neurodegeneration. Aging Cell. 2020. 2020. ↩︎